###begin article-title 0
Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells
###end article-title 0
###begin p 1
These authors contributed equally to this work
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.
###end p 2
###begin p 3
###xml 444 452 432 440 <italic>K19-Wnt1</italic>
###xml 502 505 490 493 <italic>Apc</italic>
###xml 510 513 494 497 <italic>716</italic>
###xml 505 513 493 497 <sup>&#916;<italic>716</italic></sup>
###xml 1092 1104 1053 1065 <italic>Helicobacter</italic>
###xml 1122 1130 1083 1091 <italic>K19-Wnt1</italic>
###xml 453 458 <span type="species:ncbi:10090">mouse</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 1131 1136 <span type="species:ncbi:10090">mouse</span>
The activation of Wnt/beta-catenin signalling has an important function in gastrointestinal tumorigenesis. It has been suggested that the promotion of Wnt/beta-catenin activity beyond the threshold is important for carcinogenesis. We herein investigated the role of macrophages in the promotion of Wnt/beta-catenin activity in gastric tumorigenesis. We found beta-catenin nuclear accumulation in macrophage-infiltrated dysplastic mucosa of the K19-Wnt1 mouse stomach. Moreover, macrophage depletion in ApcDelta716 mice resulted in the suppression of intestinal tumorigenesis. These results suggested the role of macrophages in the activation of Wnt/beta-catenin signalling, which thus leads to tumour development. Importantly, the conditioned medium of activated macrophages promoted Wnt/beta-catenin signalling in gastric cancer cells, which was suppressed by the inhibition of tumour necrosis factor (TNF)-alpha. Furthermore, treatment with TNF-alpha induced glycogen synthase kinase 3beta (GSK3beta) phosphorylation, which resulted in the stabilization of beta-catenin. We also found that Helicobacter infection in the K19-Wnt1 mouse stomach caused mucosal macrophage infiltration and nuclear beta-catenin accumulation. These results suggest that macrophage-derived TNF-alpha promotes Wnt/beta-catenin signalling through inhibition of GSK3beta, which may contribute to tumour development in the gastric mucosa.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 102 114 96 108 <xref ref-type="bibr" rid="b32">Taketo, 2006</xref>
###xml 661 666 634 639 <italic>et al</italic>
###xml 653 672 626 645 <xref ref-type="bibr" rid="b17">Korinek <italic>et al</italic>, 1998</xref>
###xml 690 695 663 668 <italic>et al</italic>
###xml 674 701 647 674 <xref ref-type="bibr" rid="b34">van de Wetering <italic>et al</italic>, 2002</xref>
###xml 774 779 747 752 <italic>et al</italic>
###xml 767 785 740 758 <xref ref-type="bibr" rid="b23">Oshima <italic>et al</italic>, 1995</xref>
###xml 787 791 760 764 <xref ref-type="bibr" rid="b21">2006</xref>
###xml 799 804 772 777 <italic>et al</italic>
###xml 793 810 766 783 <xref ref-type="bibr" rid="b10">Fodde <italic>et al</italic>, 2001</xref>
The canonical Wnt signalling pathway (Wnt/beta-catenin pathway) operates by stabilizing beta-catenin (Taketo, 2006). The phosphorylation of beta-catenin by glycogen synthase kinase 3beta (GSK3beta) results in degradation through the ubiquitin pathway. The binding of Wnt ligands to a Frizzled receptor leads to inhibition of the beta-catenin degradation complex consisting of APC, AXIN and GSK3beta thereby allowing the nuclear translocation of stabilized beta-catenin followed by transcriptional activation of the Wnt target genes. Wnt/beta-catenin signalling has an important function in the maintenance of intestinal stem cells and progenitor cells (Korinek et al, 1998; van de Wetering et al, 2002), and its activation causes gastrointestinal tumour development (Oshima et al, 1995, 2006; Fodde et al, 2001).
###end p 5
###begin p 6
###xml 162 165 159 162 <italic>Apc</italic>
###xml 184 206 181 203 <xref ref-type="bibr" rid="b12">Gaspar and Fodde, 2004</xref>
###xml 211 216 208 213 <italic>et al</italic>
###xml 208 222 205 219 <xref ref-type="bibr" rid="b18">Li <italic>et al</italic>, 2005</xref>
###xml 389 394 383 388 <italic>et al</italic>
###xml 380 400 374 394 <xref ref-type="bibr" rid="b1">Brabletz <italic>et al</italic>, 1998</xref>
###xml 551 556 542 547 <italic>et al</italic>
###xml 543 562 534 553 <xref ref-type="bibr" rid="b15">Kielman <italic>et al</italic>, 2002</xref>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
The activation level of Wnt/beta-catenin signalling has been reported to be a determining factor for the multiplicity of intestinal polyposis in several types of Apc gene mutant mice (Gaspar and Fodde, 2004; Li et al, 2005). Moreover, nuclear beta-catenin accumulation is predominantly observed in the invasion front of colon cancer in comparison to the non-invasive tumour area (Brabletz et al, 1998). Furthermore, sensitivity of embryonic stem (ES) cells for differentiation is inhibited by increase of Wnt/beta-catenin signalling activity (Kielman et al, 2002). These results, taken together, suggest that the promotion of the Wnt/beta-catenin activity beyond the threshold level is required for tumorigenesis, invasion and the maintenance of cell stemness.
###end p 6
###begin p 7
###xml 110 133 110 133 <xref ref-type="bibr" rid="b7">Coussens and Werb, 2002</xref>
###xml 280 285 272 277 <italic>et al</italic>
###xml 271 291 263 283 <xref ref-type="bibr" rid="b25">Pikarsky <italic>et al</italic>, 2004</xref>
###xml 324 329 316 321 <italic>et al</italic>
###xml 317 335 309 327 <xref ref-type="bibr" rid="b13">Greten <italic>et al</italic>, 2004</xref>
###xml 348 353 340 345 <italic>et al</italic>
###xml 337 359 329 351 <xref ref-type="bibr" rid="b26">Popivanova <italic>et al</italic>, 2008</xref>
###xml 535 559 524 548 <xref ref-type="bibr" rid="b9">Fodde and Brabletz, 2007</xref>
On the other hand, it has been established that inflammation has an important function in cancer development (Coussens and Werb, 2002). The activation of tumour necrosis factor (TNF)-alpha or NF-kappaB pathway is required for the development of hepatocellular carcinoma (Pikarsky et al, 2004) and intestinal tumours (Greten et al, 2004; Popivanova et al, 2008) through the induction of growth factors and suppression of apoptosis. Although several signalling pathways have been reported for the promotion of Wnt/beta-catenin activity (Fodde and Brabletz, 2007), it has not been elucidated yet whether the inflammatory response contributes to the promotion of Wnt/beta-catenin signalling during tumorigenesis.
###end p 7
###begin p 8
###xml 95 114 95 114 <italic>Helicobacter pylori</italic>
###xml 163 175 163 175 <xref ref-type="bibr" rid="b6">Correa, 2003</xref>
###xml 288 293 285 290 <italic>et al</italic>
###xml 279 299 276 296 <xref ref-type="bibr" rid="b5">Clements <italic>et al</italic>, 2002</xref>
###xml 465 466 462 463 <sub>2</sub>
###xml 471 472 468 469 <sub>2</sub>
###xml 552 557 549 554 <italic>et al</italic>
###xml 545 563 542 560 <xref ref-type="bibr" rid="b21">Oshima <italic>et al</italic>, 2006</xref>
###xml 595 596 592 593 <sub>2</sub>
###xml 689 694 686 691 <italic>et al</italic>
###xml 682 700 679 697 <xref ref-type="bibr" rid="b20">Oshima <italic>et al</italic>, 2004</xref>
###xml 702 706 699 703 <xref ref-type="bibr" rid="b24">2005</xref>
###xml 95 114 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 532 537 <span type="species:ncbi:10090">mouse</span>
Gastric cancer is the second most common cancer in the world and it is closely associated with Helicobacter pylori infection, which leads to chronic inflammation (Correa, 2003). Moreover, the activation of the Wnt/beta-catenin signalling is found in about 30% of gastric cancer (Clements et al, 2002), suggesting that Wnt activation is one of the major causes for gastric cancer development. We recently showed that cooperation of Wnt signalling and prostaglandin E2 (PGE2) pathway causes gastric cancer development in a transgenic mouse model (Oshima et al, 2006). Because the activation of PGE2 signalling induces infiltration and activation of macrophages in the gastric mucosa (Oshima et al, 2004, 2005), these results collectively suggest that activated macrophages promote the Wnt/beta-catenin signalling activity, which thus contributes to gastric cancer.
###end p 8
###begin p 9
###xml 175 187 165 177 <italic>Helicobacter</italic>
###xml 205 209 195 199 <italic>Wnt1</italic>
###xml 210 225 <span type="species:ncbi:10090">transgenic mice</span>
We herein show that TNF-alpha derived from activated macrophages promotes the Wnt/beta-catenin activity in gastric cancer cells through the suppression of GSK3beta. Moreover, Helicobacter infection in the Wnt1 transgenic mice resulted in macrophage infiltration and the activation of Wnt/beta-catenin signalling in the gastric mucosa, which thus led to gastric tumorigenesis. These results suggest that activated macrophages in inflammatory microenvironment have an important function in gastric tumorigenesis through the promotion of the Wnt/beta-catenin activity.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 28 32 28 29 <italic>&#946;</italic>
###xml 95 110 <span type="species:ncbi:10090">transgenic mice</span>
Macrophage infiltration and beta-catenin nuclear accumulation in gastric dysplasia of K19-Wnt1 transgenic mice
###end title 11
###begin p 12
###xml 0 8 0 8 <italic>K19-Wnt1</italic>
###xml 36 40 36 40 <italic>Wnt1</italic>
###xml 142 147 142 147 <italic>et al</italic>
###xml 135 153 135 153 <xref ref-type="bibr" rid="b21">Oshima <italic>et al</italic>, 2006</xref>
###xml 308 317 308 317 <xref ref-type="fig" rid="f1">Figure 1A</xref>
###xml 476 491 476 491 <xref ref-type="fig" rid="f1">Figure 1B and H</xref>
###xml 598 607 595 604 <xref ref-type="fig" rid="f1">Figure 1C</xref>
###xml 740 749 734 743 <xref ref-type="fig" rid="f1">Figure 1E</xref>
###xml 864 873 855 864 <xref ref-type="fig" rid="f1">Figure 1I</xref>
###xml 1033 1042 1021 1030 <xref ref-type="fig" rid="f1">Figure 1F</xref>
###xml 1194 1209 1182 1197 <xref ref-type="fig" rid="f1">Figure 1D and J</xref>
###xml 1320 1321 1308 1309 <italic>P</italic>
###xml 1440 1449 1428 1437 <xref ref-type="fig" rid="f1">Figure 1G</xref>
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
K19-Wnt1 transgenic mice expressing Wnt1 in the gastric epithelial cells develop sporadic dysplastic lesions in the glandular stomach (Oshima et al, 2006). In these dysplastic lesions, inflammatory cells infiltrated the submucosa, whereas cell infiltration was rarely detected in the adjacent normal mucosa (Figure 1A). By immunostaining, we found macrophage infiltration in the dysplastic mucosa, whereas tissue macrophages were only sparsely scattered in the normal mucosa (Figure 1B and H). We also found strong nuclear staining of beta-catenin in the epithelial cells of the dysplastic mucosa (Figure 1C). Notably, beta-catenin-accumulated epithelial cells were physically associated with stromal macrophages in the dysplastic lesions (Figure 1E). In contrast, mild beta-catenin accumulation was found only in the cell proliferation zone of the normal mucosa (Figure 1I). We confirmed the increase in the beta-catenin-positive index in the dysplastic lesion to be associated with the increased number of infiltrated macrophages (Figure 1F). Moreover, the number of Ki-67-positive proliferating cells increased in the dysplastic mucosa when compared with that in the adjacent normal region (Figure 1D and J). The mean Ki-67 labelling indices in the dysplastic lesions and normal mucosa were 43 and 15%, respectively (P=0.007). We also confirmed by BrdU incorporation analysis that cell proliferation was increased in dysplastic lesions (Figure 1G). On the basis of these results, we hypothesized that macrophage infiltration by inflammatory responses causes promotion of Wnt/beta-catenin signalling activity in gastric epithelial cells, which probably leads to dysplastic changes in the gastric mucosa.
###end p 12
###begin title 13
###xml 67 72 67 68 <italic>&#916;</italic>
###xml 67 75 67 71 <sup><italic>&#916;</italic>716</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Requirement of macrophages for intestinal tumour development in ApcDelta716 mice
###end title 13
###begin p 14
###xml 115 117 115 117 <italic>op</italic>
###xml 118 120 118 120 <italic>op</italic>
###xml 224 228 224 228 <italic>Csf1</italic>
###xml 248 253 248 253 <italic>et al</italic>
###xml 239 259 239 259 <xref ref-type="bibr" rid="b3">Cecchini <italic>et al</italic>, 1994</xref>
###xml 288 290 288 290 <italic>op</italic>
###xml 291 293 291 293 <italic>op</italic>
###xml 368 376 368 376 <italic>K19-C2mE</italic>
###xml 450 455 450 455 <italic>et al</italic>
###xml 443 461 443 461 <xref ref-type="bibr" rid="b20">Oshima <italic>et al</italic>, 2004</xref>
###xml 532 546 532 546 <italic>K19-C2mE op/op</italic>
###xml 562 584 562 584 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 608 610 608 610 <italic>op</italic>
###xml 611 613 611 613 <italic>op</italic>
###xml 624 627 624 627 <italic>Apc</italic>
###xml 632 635 628 631 <italic>716</italic>
###xml 627 635 627 631 <sup>&#916;<italic>716</italic></sup>
###xml 708 713 704 709 <italic>et al</italic>
###xml 701 719 697 715 <xref ref-type="bibr" rid="b23">Oshima <italic>et al</italic>, 1995</xref>
###xml 722 725 718 721 <italic>Apc</italic>
###xml 730 733 722 725 <italic>716</italic>
###xml 725 733 721 725 <sup>&#916;<italic>716</italic></sup>
###xml 791 800 783 792 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 857 866 849 858 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 884 887 876 879 <italic>Apc</italic>
###xml 892 895 880 883 <italic>716</italic>
###xml 887 895 879 883 <sup>&#916;<italic>716</italic></sup>
###xml 895 897 883 885 <italic>op</italic>
###xml 898 900 886 888 <italic>op</italic>
###xml 968 983 956 971 <xref ref-type="fig" rid="f2">Figure 2C and E</xref>
###xml 1039 1048 1027 1036 <xref ref-type="fig" rid="f2">Figure 2D</xref>
###xml 1115 1118 1103 1106 <italic>Apc</italic>
###xml 1123 1126 1107 1110 <italic>716</italic>
###xml 1118 1126 1106 1110 <sup>&#916;<italic>716</italic></sup>
###xml 1126 1128 1110 1112 <italic>op</italic>
###xml 1129 1131 1113 1115 <italic>op</italic>
###xml 1167 1170 1151 1154 <italic>Apc</italic>
###xml 1175 1178 1155 1158 <italic>716</italic>
###xml 1170 1178 1154 1158 <sup>&#916;<italic>716</italic></sup>
###xml 1459 1462 1436 1439 <italic>Apc</italic>
###xml 1467 1470 1440 1443 <italic>716</italic>
###xml 1462 1470 1439 1443 <sup>&#916;<italic>716</italic></sup>
###xml 1470 1472 1443 1445 <italic>op</italic>
###xml 1473 1475 1446 1448 <italic>op</italic>
###xml 1491 1500 1464 1473 <xref ref-type="fig" rid="f2">Figure 2F</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1179 1183 <span type="species:ncbi:10090">mice</span>
###xml 1476 1481 <span type="species:ncbi:10090">mouse</span>
To examine whether infiltrated macrophages are required for tumorigenesis, we performed crossing experiments using op/op mice, in which the number of macrophages significantly decreased in the majority of tissues because of Csf1 mutation (Cecchini et al, 1994). We first examined whether op/op mutation suppressed macrophage infiltration in the inflamed stomach using K19-C2mE mice, which develop gastritis with heavy macrophage accumulation (Oshima et al, 2004). However, mucosal macrophages were still found in the stomach of the K19-C2mE op/op compound mice (Supplementary Figure 1). We therefore crossed op/op mice with ApcDelta716 mice, a model for intestinal polyposis caused by Wnt activation (Oshima et al, 1995). ApcDelta716 mice develop numerous polyps in entire intestinal tract (Figure 2A), and macrophages were infiltrated in the polyp stroma (Figure 2B). Interestingly, ApcDelta716op/op compound mice showed dramatic suppression of intestinal polyposis (Figure 2C and E), and macrophages were not found in the polyp tissues (Figure 2D). Moreover, the number of polyps >1 mm significantly decreased in ApcDelta716op/op compound mice by 80% compared with ApcDelta716 mice. Although it remains to be elucidated as to whether the loss of the CSF-1 function affects tumorigenesis, these results suggest that macrophages were required for the growth of Wnt/beta-catenin-activated tumour cells. Consistently, the BrdU labelling index also decreased in ApcDelta716op/op mouse tumours (Figure 2F).
###end p 14
###begin title 15
###xml 19 23 19 20 <italic>&#946;</italic>
Fluctuation of Wnt/beta-catenin signalling activity in gastric cancer cells
###end title 15
###begin p 16
###xml 79 87 76 84 <italic>in vitro</italic>
###xml 220 226 214 220 <italic>CTNNB1</italic>
###xml 246 251 240 245 <italic>et al</italic>
###xml 241 257 235 251 <xref ref-type="bibr" rid="b2">Caca <italic>et al</italic>, 1999</xref>
###xml 259 281 253 275 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 2</xref>
###xml 292 298 286 292 <italic>CTNNB1</italic>
###xml 339 344 333 338 <italic>et al</italic>
###xml 331 350 325 344 <xref ref-type="bibr" rid="b31">Suriano <italic>et al</italic>, 2005</xref>
###xml 398 403 392 397 <italic>et al</italic>
###xml 391 409 385 403 <xref ref-type="bibr" rid="b19">Nojima <italic>et al</italic>, 2007</xref>
###xml 522 544 513 535 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 3</xref>
###xml 670 679 658 667 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 806 811 791 796 <italic>et al</italic>
###xml 796 817 781 802 <xref ref-type="bibr" rid="b33">van Noort <italic>et al</italic>, 2002</xref>
###xml 819 828 804 813 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 971 980 950 959 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 106 111 <span type="species:ncbi:9606">human</span>
We next examined the regulation of the Wnt/beta-catenin signalling activity by in vitro experiments using human gastric cancer cells, AGS and Kato-III. AGS cells harbour a heterozygous mutation in the beta-catenin gene (CTNNB1) at codon 34 (Caca et al, 1999; Supplementary Figure 2), whereas CTNNB1 is amplified in Kato-III cells (Suriano et al, 2005). Consistent with the previous results (Nojima et al, 2007), both cell lines showed an elevated beta-catenin/TCF transcriptional activity as detected by a TOPFLASH assay (Supplementary Figure 3). By immunocytochemistry, the cytoplasmic and nuclear accumulation of beta-catenin was found in both AGS and Kato-III cells (Figure 3A, left). We also found the nuclear localization of active form of beta-catenin, unphosphorylated on Ser37 and Thr41 (van Noort et al, 2002; Figure 3A, right), thus indicating the activation of Wnt/beta-catenin signalling. However, several cells showed a weak beta-catenin staining intensity (Figure 3A, arrowheads), suggesting that the level of Wnt/beta-catenin signalling activity varies in populations.
###end p 16
###begin p 17
###xml 199 208 193 202 <xref ref-type="fig" rid="f3">Figure 3B</xref>
###xml 386 392 377 383 <italic>CTNNB1</italic>
###xml 419 428 410 419 <xref ref-type="fig" rid="f3">Figure 3C</xref>
###xml 587 608 575 596 <xref ref-type="supplementary-material" rid="S1">Supplementary Video 1</xref>
To examine the Wnt/beta-catenin activity in the live cells, we transfected a TOPEGFP vector that expressed a green fluorescent protein (GFP) in response to beta-catenin/TCF transcriptional activity (Figure 3B), and established AGS-GFP and Kato-III-GFP cell lines. We confirmed that GFP expression was induced in beta-catenin accumulated cells after the transient transfection of mutant CTNNB1 (S33A) expression vector (Figure 3C). Importantly, we directly found by time-lapse video analysis that the Wnt/beta-catenin activity was not constant but fluctuated in individual AGS-GFP cells (Supplementary Video 1).
###end p 17
###begin p 18
###xml 262 271 256 265 <xref ref-type="fig" rid="f3">Figure 3D</xref>
###xml 359 368 353 362 <xref ref-type="fig" rid="f3">Figure 3D</xref>
###xml 534 543 528 537 <xref ref-type="fig" rid="f3">Figure 3D</xref>
To confirm the fluctuation of Wnt/beta-catenin activity, we isolated by cell sorting the high-GFP (top 5%) and low-GFP (bottom 5%) populations corresponding to high and low Wnt/beta-catenin signalling activity, respectively, from AGS-GFP and Kato-III-GFP cells (Figure 3D, left). Immediately after isolation, both populations showed distinct GFP intensities (Figure 3D, centre). Importantly, however, the GFP intensities of the isolated populations returned to a similar distribution to the unsorted cells after culturing for 5 days (Figure 3D, right). These results confirmed that the activation level of Wnt/beta-catenin signalling fluctuates in each cell.
###end p 18
###begin p 19
###xml 272 294 266 288 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 4</xref>
We next examined the level of Wnt/beta-catenin activity in cell cycle-synchronized Kato-III-GFP cells. However, the ratio of a high-GFP population did not change during cell cycling, thus indicating Wnt/beta-catenin fluctuation to be independent of the cell cycle status (Supplementary Figure 4).
###end p 19
###begin title 20
###xml 17 21 17 18 <italic>&#946;</italic>
###xml 96 101 93 94 <italic>&#945;</italic>
Promotion of Wnt/beta-catenin activity in gastric cancer cells by activated macrophages and TNF-alpha
###end title 20
###begin p 21
###xml 593 608 590 605 <xref ref-type="fig" rid="f4">Figure 4A and B</xref>
###xml 768 783 762 777 <xref ref-type="fig" rid="f4">Figure 4A and B</xref>
We next examined whether the activity of Wnt/beta-catenin signalling is promoted by activated macrophages using the GFP reporter-transfected cells. We prepared a conditioned medium of macrophage cell line, RAW264, activated with lipopolysaccharide (LPS) for 24 h; (hereafter, CM-LPS (+)). A conditioned medium from unstimulated RAW264 cells was used as the control (CM-LPS (-)). When AGS-GFP and Kato-III-GFP cells were stimulated with CM-LPS (+), the high-GFP population (corresponding to top 2% in the untreated control cells) significantly increased in a CM concentration-dependent manner (Figure 4A and B, left and top, red area). In contrast, stimulation of the cells with CM-LPS (-) or LPS alone did not affect the Wnt/beta-catenin activity in either cell line (Figure 4A and B, middle and bottom). These results indicate that the soluble factor(s) derived from activated macrophages promote the Wnt/beta-catenin activity in gastric cancer cells.
###end p 21
###begin p 22
###xml 277 286 266 275 <xref ref-type="fig" rid="f4">Figure 4C</xref>
###xml 384 393 366 375 <xref ref-type="fig" rid="f4">Figure 4D</xref>
###xml 536 565 518 547 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 5A and C</xref>
###xml 733 756 708 731 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 5B</xref>
###xml 1071 1094 1035 1058 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 6A</xref>
###xml 1127 1135 1091 1099 <italic>K19-Wnt1</italic>
###xml 1278 1301 1235 1258 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 6B</xref>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
TNF-alpha is a key mediator for inflammation and is produced by activated macrophages. Notably, treatment of the cells with a neutralizing antibody against TNF-alpha significantly suppressed the effect by CM-LPS (+) to enhance the Wnt/beta-catenin activity in both cell lines (Figure 4C). Furthermore, direct treatment with TNF-alpha increased the level of Wnt/beta-catenin activity (Figure 4D). We detected the expression of both TNF R1 and TNF R2 on AGS and Kato-III cells as well as in the primary cultured gastric epithelial cells (Supplementary Figure 5A and C and data not shown). Importantly, the blockade of either receptor by neutralizing antibody significantly suppressed the TNF-alpha-induced Wnt/beta-catenin activation (Supplementary Figure 5B). These results suggest that TNF-alpha signalling through both TNF R1 and TNF R2 is thus involved in the promotion of the Wnt/beta-catenin activity. By immunohistochemistry, we found most TNF-alpha-expressing cells in gastric tumours to be macrophages, whereas CD11c-positive dendritic cells were rarely detected (Supplementary Figure 6A). Importantly, treatment of the K19-Wnt1 mice with anti-TNF-alpha-neutralizing antibody resulted in a decrease of the beta-catenin immunostaining intensity in the dysplastic lesions (Supplementary Figure 6B).
###end p 22
###begin p 23
###xml 173 178 170 175 <italic>et al</italic>
###xml 165 184 162 181 <xref ref-type="bibr" rid="b14">Howlett <italic>et al</italic>, 2005</xref>
###xml 186 204 183 201 <xref ref-type="bibr" rid="b11">Fox and Wang, 2007</xref>
###xml 378 400 369 391 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 7</xref>
Moreover, we examined the Wnt-promoting effect of other inflammatory cytokines, IL-1beta, IL-6 and IL-11, which have an important function in gastric tumorigenesis (Howlett et al, 2005; Fox and Wang, 2007). However, these cytokines did not promote Wnt/beta-catenin activity in gastric cancer cells, although IL-1beta slightly increased the high-GFP population in AGS-GFP cells (Supplementary Figure 7). These results, taken together, suggest that TNF-alpha is one of the important macrophage-derived factors that promote the Wnt/beta-catenin activity in gastric epithelial cells and cancer cells.
###end p 23
###begin title 24
###xml 15 19 15 16 <italic>&#946;</italic>
###xml 51 56 48 49 <italic>&#945;</italic>
###xml 87 91 80 81 <italic>&#946;</italic>
Suppression of beta-catenin phosphorylation by TNF-alpha through the inhibition of GSK3beta in gastric cancer cells
###end title 24
###begin p 25
###xml 183 192 176 185 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 341 350 327 336 <xref ref-type="fig" rid="f5">Figure 5B</xref>
###xml 627 636 596 605 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 700 705 666 671 <italic>et al</italic>
###xml 694 711 660 677 <xref ref-type="bibr" rid="b8">Cross <italic>et al</italic>, 1995</xref>
###xml 819 820 780 781 <italic>P</italic>
###xml 845 846 804 805 <italic>P</italic>
###xml 1088 1097 1044 1053 <xref ref-type="fig" rid="f5">Figure 5D</xref>
###xml 1324 1329 1271 1276 <italic>et al</italic>
###xml 1317 1335 1264 1282 <xref ref-type="bibr" rid="b29">Sharma <italic>et al</italic>, 2002</xref>
###xml 1485 1494 1428 1437 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 1597 1598 1538 1539 <italic>P</italic>
###xml 1623 1624 1562 1563 <italic>P</italic>
By a flow cytometry analysis, we found that the level of unphosphorylated beta-catenin increased significantly in Kato-III cells when cells were treated with CM-LPS (+) or TNF-alpha (Figure 5A). By western blotting, we confirmed the increased level of unphosphorylated beta-catenin in Kato-III cells stimulated with CM-LPS (+) or TNF-alpha (Figure 5B). These results suggested that CM-LPS (+) or TNF-alpha suppressed the phosphorylation of beta-catenin, resulting in Wnt/beta-catenin promotion. Significantly, treatment with TNF-alpha resulted in an increase of GSK3beta phosphorylation on Ser9 both in AGS and Kato-III cells (Figure 5C), which caused the suppression of the GSK3beta activity (Cross et al, 1995). The mean relative band intensities of the phosphorylated GSK3beta to the control level were 2.03+/-0.14 (P=0.009) and 1.68+/-0.31 (P=0.03) in the AGS and Kato-III cells, respectively. Interestingly, a strong immunostaining signal for phosphorylated GSK3 was found in a sub-population of Kato-III cells that also showed nuclear accumulation of beta-catenin at the same time (Figure 5D). These results suggest that the promotion of Wnt/beta-catenin signalling is regulated by the GSK3beta phosphorylation status in gastric cancer cells. Akt is an important kinase for phosphorylation of GSK3beta at Ser9 (Sharma et al, 2002). Importantly, the active form of Akt, phosphorylated on Ser473, increased significantly after TNF-alpha stimulation in both AGS and Kato-III cells (Figure 5C). The mean relative band intensities of the phosphorylated Akt to the control level were 2.08+/-0.16 (P=0.005) and 1.81+/-0.19 (P=0.002) in the AGS and Kato-III cells, respectively. These results suggest that TNF-alpha accelerates the GSK3beta phosphorylation through the activation of the Akt pathway.
###end p 25
###begin title 26
###xml 3 8 3 4 <italic>&#954;</italic>
###xml 39 43 35 36 <italic>&#946;</italic>
NF-kappaB-independent promotion of Wnt/beta-catenin activity in gastric cancer cells
###end title 26
###begin p 27
###xml 278 287 255 264 <xref ref-type="fig" rid="f6">Figure 6A</xref>
###xml 444 453 410 419 <xref ref-type="fig" rid="f6">Figure 6B</xref>
To examine whether NF-kappaB is involved in Wnt/beta-catenin promotion by activated macrophages, we transfected IkappaB-superrepressor (IkappaBSR) expression vector into AGS-GFP cells and established two sublines, in which TNF-alpha-induced NF-kappaB activation was suppressed (Figure 6A). Notably, the TNF-alpha- or CM-LPS (+)-induced promotion of the Wnt/beta-catenin activity did not change in either of IkappaBSR-transfected AGS-GFP cells (Figure 6B), thus suggesting the existence of an NF-kappaB-independent mechanism for the TNF-alpha-induced Wnt/beta-catenin promotion.
###end p 27
###begin p 28
###xml 264 273 255 264 <xref ref-type="fig" rid="f6">Figure 6C</xref>
###xml 421 430 412 421 <xref ref-type="fig" rid="f6">Figure 6C</xref>
When Kato-III cells were treated with the protein synthesis inhibitor cycloheximide, the unphosphorylated beta-catenin-positive population decreased gradually in an incubation time-dependent manner, probably due to the phosphorylation of beta-catenin by GSK3beta (Figure 6C, black lines). However, the simultaneous treatment with CM-LPS (+) significantly suppressed the cycloheximide-induced decrease of this population (Figure 6C, red lines). Therefore, it is also possible that activated macrophages suppress beta-catenin phosphorylation independent of protein synthesis, which is consistent with the results that the transcription factor NF-kappaB pathway is not involved in the suppression of beta-catenin phosphorylation.
###end p 28
###begin title 29
###xml 32 36 32 33 <italic>&#946;</italic>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Macrophage infiltration and Wnt/beta-catenin activation in mouse gastric epithelial cells by Helicobacter infection
###end title 29
###begin p 30
###xml 125 133 122 130 <italic>H. felis</italic>
###xml 155 164 152 161 <italic>H. pylori</italic>
###xml 183 191 180 188 <italic>K19-Wnt1</italic>
###xml 224 232 221 229 <italic>H. felis</italic>
###xml 293 301 290 298 <italic>H. felis</italic>
###xml 327 338 324 335 <xref ref-type="fig" rid="f7">Figure 7A&#8211;C</xref>
###xml 426 437 423 434 <xref ref-type="fig" rid="f7">Figure 7G&#8211;I</xref>
###xml 480 488 477 485 <italic>K19-Wnt1</italic>
###xml 633 642 630 639 <xref ref-type="fig" rid="f1">Figure 1A</xref>
###xml 821 839 815 833 <xref ref-type="fig" rid="f7">Figure 7D, J and M</xref>
###xml 985 992 976 983 <italic>in vivo</italic>
###xml 1120 1138 1111 1129 <xref ref-type="fig" rid="f7">Figure 7E, K and N</xref>
###xml 1169 1170 1160 1161 <sup>+</sup>
###xml 1172 1173 1163 1164 <sup>+</sup>
###xml 1235 1243 1226 1234 <italic>H. felis</italic>
###xml 1322 1340 1313 1331 <xref ref-type="fig" rid="f7">Figure 7F, L and O</xref>
###xml 1426 1438 1417 1429 <italic>Helicobacter</italic>
###xml 1603 1606 1591 1594 <italic>Apc</italic>
###xml 1611 1614 1595 1598 <italic>716</italic>
###xml 1606 1614 1594 1598 <sup>&#916;<italic>716</italic></sup>
###xml 1639 1647 1623 1631 <italic>H. felis</italic>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 125 133 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 155 164 <span type="species:ncbi:210">H. pylori</span>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 224 232 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 293 301 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 1235 1243 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 1615 1619 <span type="species:ncbi:10090">mice</span>
###xml 1639 1647 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
We next examined whether Wnt/beta-catenin signalling is activated by infection-associated inflammation in the mouse stomach. H. felis, a close relative of H. pylori was infected into K19-Wnt1 mouse stomach. At 8 weeks after H. felis infection, the infiltration of macrophages was found in the H. felis-infected gastric mucosa (Figure 7A-C), whereas tissue macrophages were sparsely scattered in the non-infected mucosal area (Figure 7G-I). Such an inflamed mucosa in the infected K19-Wnt1 mice was only detected by histological examinations, and this inflamed mucosa was distinct from the spontaneously developed dysplastic lesions (Figure 1A). Importantly, the number of beta-catenin-accumulated epithelial cells increased significantly in the infected and inflamed mucosa compared with that in the non-inflamed mucosa (Figure 7D, J and M). These results suggest that the infection-associated inflammation promotes the Wnt/beta-catenin signalling activity in gastric epithelial cells in vivo. Moreover, in the inflamed mucosa, the epithelial cell proliferation detected by Ki-67 immunostaining significantly increased (Figure 7E, K and N). Furthermore, the number of H+/K+-ATPase-positive parietal cells decreased dramatically in the H. felis-infected area, thus indicating the suppression of epithelial differentiation (Figure 7F, L and O). These results, taken together, suggest that infiltrated macrophages in response to Helicobacter infection have an important function in the activation of Wnt/beta-catenin signalling, thereby enhancing the proliferation and suppression of differentiation. When ApcDelta716 mice were infected with H. felis, we did not find any beta-catenin-accumulated dysplastic cells in the inflamed gastric mucosa (data not shown). Therefore, it is possible that the basal activation level of Wnt/beta-catenin signalling is required for its promotion.
###end p 30
###begin title 31
###xml 22 30 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Tumour development in H. felis-infected K19-Wnt1 mouse stomach
###end title 31
###begin p 32
###xml 28 36 28 36 <italic>H. felis</italic>
###xml 87 95 87 95 <italic>K19-Wnt1</italic>
###xml 115 123 115 123 <italic>K19-Wnt1</italic>
###xml 173 181 173 181 <italic>H. felis</italic>
###xml 230 238 230 238 <italic>H. felis</italic>
###xml 264 279 264 279 <xref ref-type="fig" rid="f8">Figure 8A and E</xref>
###xml 340 348 340 348 <italic>H. felis</italic>
###xml 358 366 358 366 <italic>K19-Wnt1</italic>
###xml 396 411 396 411 <xref ref-type="fig" rid="f8">Figure 8B and F</xref>
###xml 479 494 479 494 <xref ref-type="fig" rid="f8">Figure 8C and G</xref>
###xml 554 562 554 562 <italic>K19-Wnt1</italic>
###xml 611 626 611 626 <xref ref-type="fig" rid="f8">Figure 8D and H</xref>
###xml 28 36 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 173 181 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 230 238 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 340 348 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 381 386 <span type="species:ncbi:10090">mouse</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
We finally examined whether H. felis infection contributes to gastric tumorigenesis in K19-Wnt1 mice. Importantly, K19-Wnt1 mice developed gastric tumours at 20 weeks after H. felis infection, whereas no tumours were found in the H. felis-infected wild-type mice (Figure 8A and E). Histologically, submucosal infiltration was found in both H. felis-infected K19-Wnt1 and wild-type mouse stomach (Figure 8B and F). Although macrophage infiltration was detected in both genotypes (Figure 8C and G), dysplastic epithelial cells were evident in the infected K19-Wnt1 tumours but not in the wild-type mouse stomach (Figure 8D and H). These results, taken together, suggest that infection-associated inflammation has an important function in gastric tumorigenesis through the promotion of the Wnt/beta-catenin activity beyond the basal activation level.
###end p 32
###begin title 33
Discussion
###end title 33
###begin title 34
Macrophage infiltration and cancer development, progression and stemness
###end title 34
###begin p 35
###xml 89 92 86 89 <italic>APC</italic>
###xml 96 102 93 99 <italic>CTNNB1</italic>
###xml 311 335 305 329 <xref ref-type="bibr" rid="b9">Fodde and Brabletz, 2007</xref>
###xml 444 449 435 440 <italic>et al</italic>
###xml 435 455 426 446 <xref ref-type="bibr" rid="b1">Brabletz <italic>et al</italic>, 1998</xref>
###xml 612 618 600 606 <italic>CTNNB1</italic>
The activation of Wnt/beta-catenin signalling by genetic alteration, such as mutation in APC or CTNNB1, is responsible for gastrointestinal tumorigenesis. However, accumulating evidence suggests that further promotion of the Wnt/beta-catenin activity has an important function in tumour growth and progression (Fodde and Brabletz, 2007). For example, increased beta-catenin accumulation is found in the invasion front of colon cancer (Brabletz et al, 1998). We herein demonstrated direct evidence that the Wnt/beta-catenin activity fluctuates in individual cancer cells that carry the same genetic alteration in CTNNB1. Accordingly, Wnt/beta-catenin signalling can be promoted beyond the basal activated level caused by genetic alteration, and such promotion may have an important function in both tumour development and progression.
###end p 35
###begin p 36
###xml 51 52 51 52 <sub>2</sub>
###xml 180 185 177 182 <italic>et al</italic>
###xml 173 191 170 188 <xref ref-type="bibr" rid="b22">Oshima <italic>et al</italic>, 1996</xref>
###xml 203 208 200 205 <italic>et al</italic>
###xml 193 214 190 211 <xref ref-type="bibr" rid="b30">Sonoshita <italic>et al</italic>, 2001</xref>
###xml 263 264 260 261 <sub>2</sub>
###xml 349 354 346 351 <italic>et al</italic>
###xml 342 360 339 357 <xref ref-type="bibr" rid="b21">Oshima <italic>et al</italic>, 2006</xref>
###xml 375 376 372 373 <sub>2</sub>
###xml 460 461 457 458 <sub>2</sub>
###xml 530 538 527 535 <italic>K19-C2mE</italic>
###xml 552 557 549 554 <italic>et al</italic>
###xml 545 563 542 560 <xref ref-type="bibr" rid="b20">Oshima <italic>et al</italic>, 2004</xref>
###xml 648 656 645 653 <italic>K19-Wnt1</italic>
###xml 713 714 710 711 <sub>2</sub>
###xml 921 922 911 912 <sub>2</sub>
###xml 328 333 <span type="species:ncbi:10090">mouse</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
We have previously shown the induction of COX-2/PGE2 pathway to have an important function in the intestinal tumorigenesis that is triggered by Wnt/beta-catenin activation (Oshima et al, 1996; Sonoshita et al, 2001). The simultaneous induction of both Wnt and PGE2 pathways is also responsible for gastric tumour development in mouse models (Oshima et al, 2006). Although PGE2 may have multiple functions for tumorigenesis, we previously found an increased PGE2 level to result in macrophage accumulation in the gastric mucosa of K19-C2mE mice (Oshima et al, 2004). Accordingly, it is possible that macrophage infiltration in dysplastic lesions of K19-Wnt1 mice is caused by the spontaneous induction of COX-2/PGE2 pathway. We herein show that Wnt/beta-catenin signalling is promoted by macrophage-derived TNF-alpha, which contributes to gastric tumorigenesis. It is therefore possible that the induction of the COX-2/PGE2 pathway promotes Wnt/beta-catenin signalling through the enhancement of macrophage infiltration, which is responsible for tumour development.
###end p 36
###begin p 37
###xml 89 97 86 94 <italic>K19-C2mE</italic>
###xml 106 114 103 111 <italic>H. felis</italic>
###xml 124 127 121 124 <italic>Apc</italic>
###xml 132 135 125 128 <italic>716</italic>
###xml 127 135 124 128 <sup>&#916;<italic>716</italic></sup>
###xml 193 194 186 187 <sub>2</sub>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 106 114 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
On the other hand, Wnt/beta-catenin signalling is not activated in the stomach of either K19-C2mE mice or H. felis-infected ApcDelta716 mice, thus indicating that the induction of the COX-2/PGE2 pathway and subsequent macrophage infiltration are not sufficient for the promotion of Wnt/beta-catenin in gastric epithelial cells. It is conceivable that the basal activation of the Wnt/beta-catenin pathway by genetic alteration is required for the promotion of Wnt/beta-catenin signalling.
###end p 37
###begin p 38
###xml 192 197 186 191 <italic>et al</italic>
###xml 184 203 178 197 <xref ref-type="bibr" rid="b17">Korinek <italic>et al</italic>, 1998</xref>
###xml 320 325 311 316 <italic>et al</italic>
###xml 312 331 303 322 <xref ref-type="bibr" rid="b15">Kielman <italic>et al</italic>, 2002</xref>
###xml 793 798 774 779 <italic>et al</italic>
###xml 788 804 769 785 <xref ref-type="bibr" rid="b27">Pull <italic>et al</italic>, 2005</xref>
The activation of Wnt/beta-catenin pathway is also suggested to be important for stemness. Wnt/beta-catenin signalling is required for the maintenance of normal intestinal stem cells (Korinek et al, 1998), and the increase in the Wnt/beta-catenin activity contributes to the maintenance of stemness in ES cells (Kielman et al, 2002). Accordingly, it is possible that the increased Wnt/beta-catenin activity is also important for the maintenance of cancer stem cells. Therefore, infiltrated macrophages in tumour tissues may be an important component of niche for cancer stem cells by promoting Wnt/beta-catenin signalling through TNF-alpha pathway. This hypothesis is supported by the results that macrophages are required for the maintenance of progenitor cells in the intestinal crypt (Pull et al, 2005).
###end p 38
###begin title 39
###xml 33 38 33 34 <italic>&#945;</italic>
###xml 68 72 64 65 <italic>&#946;</italic>
Possible pathways other than TNF-alpha for the promotion of the Wnt/beta-catenin signalling activity
###end title 39
###begin p 40
###xml 144 149 137 142 <italic>et al</italic>
###xml 136 155 129 148 <xref ref-type="bibr" rid="b14">Howlett <italic>et al</italic>, 2005</xref>
###xml 157 175 150 168 <xref ref-type="bibr" rid="b11">Fox and Wang, 2007</xref>
###xml 480 488 456 464 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 735 740 702 707 <italic>et al</italic>
###xml 728 746 695 713 <xref ref-type="bibr" rid="b28">Rasola <italic>et al</italic>, 2006</xref>
###xml 884 889 845 850 <italic>et al</italic>
###xml 879 895 840 856 <xref ref-type="bibr" rid="b35">Yang <italic>et al</italic>, 2006</xref>
It has been shown that inflammatory cytokines, TNF-alpha, IL-1beta, IL-6 or IL-11, have an important function in gastric tumorigenesis (Howlett et al, 2005; Fox and Wang, 2007). Among these cytokines, TNF-alpha is the most potent Wnt/beta-catenin-promoting factor, although IL-1beta slightly increases Wnt signalling in AGS cells. However, the increased level of the Wnt/beta-catenin activity by CM-LPS (+) is significantly higher than that by TNF-alpha alone in both cell lines (Figure 4), thus suggesting the effect of other macrophage-derived factors on Wnt/beta-catenin promotion. It has been reported that hepatocyte growth factor activates Wnt/beta-catenin signalling through the tyrosine phosphorylation of beta-catenin (Rasola et al, 2006), and platelet-derived growth factor also promotes Wnt/beta-catenin signalling through suppression of beta-catenin phosphorylation (Yang et al, 2006). It is therefore possible that these factor(s) contribute to Wnt/beta-catenin promotion together with TNF-alpha in gastric tumorigenesis.
###end p 40
###begin p 41
###xml 179 184 176 181 <italic>et al</italic>
###xml 168 190 165 187 <xref ref-type="bibr" rid="b26">Popivanova <italic>et al</italic>, 2008</xref>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Recently, using a colon tumour mouse model, TNF R1 signalling in bone marrow-derived cells has been shown to indirectly enhance epithelial Wnt/beta-catenin signalling (Popivanova et al, 2008). Accordingly, it is possible that TNF-alpha signalling, not only in epithelial cells but also in stromal cells, may therefore contribute to the promotion of Wnt/beta-catenin signalling in cancer cells.
###end p 41
###begin title 42
###xml 17 21 17 18 <italic>&#946;</italic>
Promotion of Wnt/beta-catenin signalling in cancer cells that retain wild-type CTNNB1
###end title 42
###begin p 43
###xml 374 380 355 361 <italic>CTNNB1</italic>
###xml 390 395 371 376 <italic>et al</italic>
###xml 382 401 363 382 <xref ref-type="bibr" rid="b31">Suriano <italic>et al</italic>, 2005</xref>
###xml 589 595 560 566 <italic>CTNNB1</italic>
###xml 643 665 611 633 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 2</xref>
###xml 672 677 640 645 <italic>et al</italic>
###xml 667 683 635 651 <xref ref-type="bibr" rid="b2">Caca <italic>et al</italic>, 1999</xref>
###xml 892 898 850 856 <italic>CTNNB1</italic>
###xml 1015 1021 970 976 <italic>CTNNB1</italic>
###xml 1090 1095 1045 1050 <italic>et al</italic>
###xml 1081 1101 1036 1056 <xref ref-type="bibr" rid="b5">Clements <italic>et al</italic>, 2002</xref>
###xml 1178 1183 1133 1138 <italic>et al</italic>
###xml 1172 1189 1127 1144 <xref ref-type="bibr" rid="b4">Cheng <italic>et al</italic>, 2005</xref>
###xml 1235 1240 1190 1195 <italic>et al</italic>
###xml 1228 1246 1183 1201 <xref ref-type="bibr" rid="b19">Nojima <italic>et al</italic>, 2007</xref>
###xml 1308 1313 1260 1265 <italic>et al</italic>
###xml 1304 1319 1256 1271 <xref ref-type="bibr" rid="b16">Kim <italic>et al</italic>, 2007</xref>
###xml 1436 1442 1385 1391 <italic>CTNNB1</italic>
###xml 991 996 <span type="species:ncbi:9606">human</span>
We show here that TNF-alpha stimulation promotes the Wnt/beta-catenin signalling activity through the suppression of beta-catenin phosphorylation by GSK3beta. Therefore, the expression of wild-type beta-catenin is required for the promotion of Wnt/beta-catenin signalling in epithelial cells as well as cancer cells. Because Kato-III cells have a multicopy of the wild-type CTNNB1 (Suriano et al, 2005), TNF-alpha stimulation suppresses phosphorylation of these beta-catenin, thus leading to the enhancement of Wnt/beta-catenin signalling. On the other hand, AGS cells possess mutation in CTNNB1 close to the phosphorylation site of GSK3beta (Supplementary Figure 2; Caca et al, 1999), which causes the activation of the basal Wnt/beta-catenin signalling. It is therefore possible that TNF-alpha stimulation suppresses phosphorylation of wild-type beta-catenin expressed from retained intact CTNNB1, which contributes to the promotion of the total Wnt/beta-catenin activity of AGS cells. In human gastric cancer, a CTNNB1 mutation is found in about 30% of the Wnt-activated cases (Clements et al, 2002). However, either a somatic mutation or downregulation of E-cadherin (Cheng et al, 2005), secreted frizzled-related proteins (Nojima et al, 2007), or beta-TrCP, a component of ubiquitin ligase complex (Kim et al, 2007) is found in gastric cancer, which leads to the basal activation of Wnt/beta-catenin signalling without mutation in CTNNB1. These results, taken together, suggest that wild-type beta-catenin expressed in gastric cancer cells is stabilized by inflammatory macrophages, thus resulting in the promotion of Wnt/beta-catenin signalling, which contributes to cancer development, progression and the maintenance of cancer stem cells.
###end p 43
###begin p 44
###xml 156 157 156 157 <sub>2</sub>
Accordingly, the present results suggest that the suppression of macrophage infiltration and its activation by anti-inflammatory drugs or inhibitors for PGE2 pathway is, therefore, a possible strategy for chemoprevention against gastric cancer.
###end p 44
###begin title 45
Materials and methods
###end title 45
###begin title 46
Animal experiments
###end title 46
###begin p 47
###xml 20 28 20 28 <italic>K19-Wnt1</italic>
###xml 33 41 33 41 <italic>K19-C2mE</italic>
###xml 96 101 96 101 <italic>et al</italic>
###xml 89 107 89 107 <xref ref-type="bibr" rid="b20">Oshima <italic>et al</italic>, 2004</xref>
###xml 109 113 109 113 <xref ref-type="bibr" rid="b21">2006</xref>
###xml 125 133 125 133 <italic>K19-Wnt1</italic>
###xml 147 151 147 151 <italic>Wnt1</italic>
###xml 161 169 161 169 <italic>K19-C2mE</italic>
###xml 301 309 301 309 <italic>K19-Wnt1</italic>
###xml 362 363 362 363 <italic>n</italic>
###xml 471 479 471 479 <italic>H. felis</italic>
###xml 537 542 537 542 <italic>et al</italic>
###xml 530 548 530 548 <xref ref-type="bibr" rid="b20">Oshima <italic>et al</italic>, 2004</xref>
###xml 551 559 551 559 <italic>H. felis</italic>
###xml 590 591 590 591 <sup>8</sup>
###xml 612 619 612 619 <italic>K19-Wnt</italic>
###xml 626 629 626 629 <italic>Apc</italic>
###xml 634 637 630 633 <italic>716</italic>
###xml 629 637 629 633 <sup>&#916;<italic>716</italic></sup>
###xml 651 656 647 652 <italic>et al</italic>
###xml 644 662 640 658 <xref ref-type="bibr" rid="b23">Oshima <italic>et al</italic>, 1995</xref>
###xml 697 705 693 701 <italic>K19-Wnt1</italic>
###xml 753 761 749 757 <italic>H. felis</italic>
###xml 775 776 771 772 <italic>n</italic>
###xml 808 811 804 807 <italic>Apc</italic>
###xml 816 819 808 811 <italic>716</italic>
###xml 811 819 807 811 <sup>&#916;<italic>716</italic></sup>
###xml 867 868 859 860 <italic>n</italic>
###xml 893 901 885 893 <italic>H. felis</italic>
###xml 1011 1020 1003 1012 <xref ref-type="fig" rid="f7">Figure 7B</xref>
###xml 1023 1026 1015 1018 <italic>Apc</italic>
###xml 1031 1034 1019 1022 <italic>716</italic>
###xml 1026 1034 1018 1022 <sup>&#916;<italic>716</italic></sup>
###xml 1058 1060 1046 1048 <italic>op</italic>
###xml 1061 1063 1049 1051 <italic>op</italic>
###xml 1104 1107 1092 1095 <italic>Apc</italic>
###xml 1112 1115 1096 1099 <italic>716</italic>
###xml 1107 1115 1095 1099 <sup>&#916;<italic>716</italic></sup>
###xml 1115 1117 1099 1101 <italic>op</italic>
###xml 1118 1120 1102 1104 <italic>op</italic>
###xml 1136 1137 1120 1121 <italic>n</italic>
###xml 1164 1167 1148 1151 <italic>Apc</italic>
###xml 1172 1175 1152 1155 <italic>716</italic>
###xml 1167 1175 1151 1155 <sup>&#916;<italic>716</italic></sup>
###xml 1182 1183 1162 1163 <italic>n</italic>
###xml 1205 1208 1185 1188 <italic>Apc</italic>
###xml 1213 1216 1189 1192 <italic>716</italic>
###xml 1208 1216 1188 1192 <sup>&#916;<italic>716</italic></sup>
###xml 1221 1224 1197 1200 <italic>Apc</italic>
###xml 1229 1232 1201 1204 <italic>716</italic>
###xml 1224 1232 1200 1204 <sup>&#916;<italic>716</italic></sup>
###xml 1232 1234 1204 1206 <italic>op</italic>
###xml 1235 1237 1207 1209 <italic>op</italic>
###xml 42 57 <span type="species:ncbi:10090">transgenic mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 310 325 <span type="species:ncbi:10090">transgenic mice</span>
###xml 471 479 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 551 559 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 753 761 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 820 824 <span type="species:ncbi:10090">mice</span>
###xml 893 901 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1176 1180 <span type="species:ncbi:10090">mice</span>
###xml 1238 1242 <span type="species:ncbi:10090">mice</span>
###xml 1395 1399 <span type="species:ncbi:10090">mice</span>
The construction of K19-Wnt1 and K19-C2mE transgenic mice has been described previously (Oshima et al, 2004, 2006). Briefly, K19-Wnt1 mice express Wnt1, whereas K19-C2mE mice express COX-2 and mPGES-1 in gastric epithelial cells under transcriptional regulation by cytokeratin 19 (K19) gene promoter. K19-Wnt1 transgenic mice were euthanized at 30 weeks of age (n=10), and the glandular stomach was fixed with 4% paraformaldehyde and processed for histological analysis. H. felis (ATCC49179) was cultured as previously described (Oshima et al, 2004). H. felis bacteria were inoculated at 108 per mouse p.o. into K19-Wnt mice, ApcDelta716 mice (Oshima et al, 1995) and wild-type mice. The infected K19-Wnt1 mice were examined at 8 and 20 weeks after the H. felis inoculation (n=3 for each mice). The infected ApcDelta716 mice were examined at 6 weeks after infection (n=4). The localization of H. felis-infected mucosa at 8 weeks was estimated by the detection of bacteria using microscope with x 100 objective (Figure 7B). ApcDelta716 mice were crossed with op/op mice (The Jackson Laboratory) to obtain ApcDelta716op/op compound mice (n=3) and littermate control ApcDelta716 mice (n=3). The intestine of ApcDelta716 and ApcDelta716op/op mice was examined at 12 weeks of age, and the total number of polyps was determined using a dissecting microscope. For scoring the BrdU labelling index, the mice were injected i.p. with 200 mul of BrdU solution (Roche) and then the tissue specimens were processed for immunostaining using anti-BrdU antibody. All animal experiments were carried out according to the protocol approved by the Committee on Animal Experimentation of Kanazawa University.
###end p 47
###begin title 48
Histology and immunostaining
###end title 48
###begin p 49
###xml 314 315 310 311 <sup>+</sup>
###xml 317 318 313 314 <sup>+</sup>
###xml 561 562 554 555 <sup>+</sup>
###xml 564 565 557 558 <sup>+</sup>
###xml 881 887 <span type="species:ncbi:9793">donkey</span>
###xml 893 898 <span type="species:ncbi:10090">mouse</span>
###xml 927 930 <span type="species:ncbi:10116">rat</span>
###xml 934 940 <span type="species:ncbi:9986">rabbit</span>
The stomach tissues were fixed in 4% paraformaldehyde, paraffin-embedded and sectioned at 4 mum thickness. These sections were stained with H&E. Serial sections were immunostained with antibodies for Ki-67 (DakoCytomation), F4/80 (Serotec), unphosphorylated (activated) beta-catenin on Ser37 and Thr41 (Upstate), H+/K+-ATPase (MBL, Nagoya, Japan) or BrdU (BD Biosciences) as the primary antibody. The staining signals were visualized using the Vectorstain Elite Kit (Vector Laboratories). The number of positive stained cells for F4/80, beta-catenin, Ki-67 or H+/K+-ATPase was scored in 20 randomly selected gastric glands and the mean values were calculated. The number of BrdU-positive cells and the total number of nuclei was counted in five microscopic fields and then the mean value was calculated as the BrdU labelling index. For immunofluorescence staining, Alexa Fluor 594 donkey anti-mouse IgG or Alexa Fluor 488 anti-rat or rabbit IgG (Molecular Probes) was used as the secondary antibody.
###end p 49
###begin title 50
Plasmid vector construction
###end title 50
###begin p 51
For the construction of the beta-catenin/TCF reporter plasmid with GFP (TOPEGFP vector), cDNA encoding EGFP was excised from pIRES2-EGFP (Clontech) and replaced with luciferase gene in TOPFLASH plasmid (Upstate). TOPEGFP reporter plasmid was transfected to cells using Effectene Transfection Reagent (Qiagen), and stable cell lines were then obtained by cell sorting. The Wnt/beta-catenin activity using TOPEGFP reporter was measured by flow cytometry (see below). pcDNA3-S33A-beta-catenin and pBSFI-IkappaBSR plasmids were kindly provided by Dr Peter Vogt at the Scripps Research Institute. pcDNA3-S33A-beta-catenin was transiently transfected to Kato-III-GFP cells for 72 h to express stabilized mutant beta-catenin. pBSFI-IkappaBSR was transfected to AGS-GFP cells to establish the sublines in which the NF-kappaB pathway is suppressed.
###end p 51
###begin title 52
Immunocytochemistry
###end title 52
###begin p 53
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 350 353 <span type="species:ncbi:10116">rat</span>
Gastric cancer cells grown on cover slips were fixed with 10% neutral buffered formalin and permeabilized with 0.1% Triton X-100 in PBS. Anti-total beta-catenin antibody (Sigma), anti-unphosphorylated beta-catenin antibody (Upstate), or anti-phosphorylated GSK3 (Cell Signaling) was used as the primary antibody, and anti-mouse IgG Alexa 594 or anti-rat IgG Alexa 488 (Molecular Probes) were used as the secondary antibody. Next, cover slips were mounted using VECTASHIELD Mounting Medium (Vector Laboratories) that contained DAPI for nuclear staining.
###end p 53
###begin title 54
Cell culture and preparation of conditioned medium
###end title 54
###begin p 55
###xml 233 234 227 228 <sub>2</sub>
###xml 378 397 372 391 <italic>Salmonella enterica</italic>
###xml 407 418 401 412 <italic>typhimurium</italic>
###xml 240 245 <span type="species:ncbi:10090">mouse</span>
###xml 378 397 <span type="species:ncbi:28901">Salmonella enterica</span>
###xml 752 757 <span type="species:ncbi:10090">mouse</span>
Gastric cancer cell lines, AGS (ATCC) and Kato-III (Cell Resource Center for Biomedical Research, Tohoku University, Japan) were cultured in RPMI1640 medium supplemented with 10% FBS in a humidified incubator at 37degreesC with 5% CO2. The mouse macrophage cell line RAW264 (RIKEN BioResource Center, Tsukuba, Japan) was cultured in RPMI1640, and treated with LPS purified from Salmonella enterica serotype typhimurium (Sigma) at 100 ng/ml for 24 h. The conditioned medium, CM-LPS (+) was collected and used for the Wnt/beta-catenin activation experiments. The control conditioned medium, CM-LPS (-) was prepared from non-stimulated RAW264 cell culture. For either the stimulation or inhibition of the TNF-alpha pathway, TNF-alpha (Calbiochem) or anti-mouse TNF-alpha-neutralizing antibody (R&D systems) was added, respectively, in the culture medium at the indicated concentration.
###end p 55
###begin title 56
###xml 3 8 3 4 <italic>&#954;</italic>
NF-kappaB ELISA assay
###end title 56
###begin p 57
The nuclear extract was prepared from AGS-GFP cells or pBSFI-IkappaBSR-transfected clones (IkappaBSR nos. 1 and 2) using NE-PER Nuclear Extraction Reagents (Pierce), and the NF-kappaB activity was measured using an NF-kappaB p65 Transcription Factor Assay Kit (Active Motif). These cell lines were also used for the flow cytometry analysis.
###end p 57
###begin title 58
Flow cytometry analysis
###end title 58
###begin p 59
After treatment with CM-LPS (+), CM-LPS (-), LPS or TNF-alpha at the indicated concentrations for 48 h, AGS-GFP, Kato-III-GFP cells or pBSFI-IkappaBSR-transfected cells (IkappaBSR nos. 1 and 2) were washed with PBS containing 2% FCS and stained with 5 mug/ml propidium iodide to exclude dead cells. GFP fluorescence was examined with FACSCalibur (Becton Dickinson). A fluorescence intensity corresponding to the top 2% of the control untreated cells was judged as the high-GFP population (high-Wnt/beta-catenin signalling population).
###end p 59
###begin p 60
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
For the analysis of intracellular unphosphorylated (active) beta-catenin, cells were fixed in 1-2% paraformaldehyde and permeabilized using 0.05% Triton X-100 in PBS containing 2% FCS. Next, the cells were incubated with anti-unphosphorylated beta-catenin antibody on Ser37 and Thr41 (Upstate) followed by anti-mouse IgG-Alexa 488 (Molecular Probes), and examined with FACSCalibur. For the inhibition of protein translation, the cells were treated with cycloheximide (Sigma) at 0.5 mug/ml for the indicated time, and then the intracellular unphosphorylated beta-catenin was measured by a FACS analysis as described above.
###end p 60
###begin title 61
Western blotting analysis
###end title 61
###begin p 62
###xml 456 457 439 440 <italic>g</italic>
For the detection of total beta-catenin and unphosphorylated beta-catenin, the cells were stimulated with CM-LPS (+) or TNF-alpha at 10 ng/ml for 24 h. For the detection of total or phosphorylated GSK3beta (Ser9), and phosphorylated Akt (Ser473), the cells were cultured in serum-free conditions for 24 h followed by stimulation with TNF-alpha at 100 ng/ml for 24 h. Next, the cells were lysed and sonicated in lysis buffer. After centrifugation at 20 000 g, 10 mug of the supernatant protein was separated in a 10% SDS-polyacrylamide gel. Antibodies for unphosphorylated (active) beta-catenin (Upstate), total beta-catenin (Sigma), total GSK3beta (BD Biosciences), phosphorylated GSK3 on Ser9 and 21 (Cell Signaling), and phosphorylated Akt at Ser473 (Cell Signaling) were used as the primary antibody. beta-Actin was used as an internal control. The ECL detection system (Amersham Biosciences) was used to detect specific signals.
###end p 62
###begin title 63
Statistical analysis
###end title 63
###begin p 64
###xml 49 50 49 50 <italic>t</italic>
###xml 102 103 102 103 <italic>P</italic>
The data were analysed by the paired or unpaired t-test using Microsoft Excel (Microsoft). A value of P<0.05 was accepted as statistically significant.
###end p 64
###begin title 65
Supplementary Material
###end title 65
###begin p 66
Supplementary Figures
###end p 66
###begin p 67
Supplementary Video 1
###end p 67
###begin p 68
Supplementary Figures Legends
###end p 68
###begin p 69
Supplementary Methods
###end p 69
###begin p 70
We thank Manami Watanabe for her valuable technical contribution. This study was supported by Grant-in-Aid for the Third-Term Comprehensive Control Strategy for Cancer from the Ministry of Health, Labour and Welfare of Japan, Grant-in-Aid for Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Takeda Science Foundation, Japan.
###end p 70
###begin article-title 71
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.
###end article-title 71
###begin article-title 72
beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
###end article-title 72
###begin article-title 73
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.
###end article-title 73
###begin article-title 74
Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination.
###end article-title 74
###begin article-title 75
###xml 4 12 1 9 <italic>-Catenin</italic>
beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
###end article-title 75
###begin article-title 76
###xml 0 12 0 12 <italic>Helicobacter</italic>
###xml 12 18 12 18 <italic>pylori</italic>
Helicobacterpylori infection and gastric cancer.
###end article-title 76
###begin article-title 77
Inflammation and cancer.
###end article-title 77
###begin article-title 78
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
###end article-title 78
###begin article-title 79
Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
###end article-title 79
###begin article-title 80
###xml 0 3 0 3 <italic>APC</italic>
APC, signal transduction and genetic instability in colorectal cancer.
###end article-title 80
###begin article-title 81
Inflammation, atrophy and gastric cancer.
###end article-title 81
###begin article-title 82
###xml 0 3 0 3 <italic>APC</italic>
APC dosage effects in tumorigenesis and stem cell differentiation.
###end article-title 82
###begin article-title 83
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.
###end article-title 83
###begin article-title 84
Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
###end article-title 84
###begin article-title 85
###xml 0 3 0 3 <italic>Apc</italic>
Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
###end article-title 85
###begin article-title 86
###xml 29 34 26 31 <italic>-TrCP</italic>
Somatic mutations of the beta-TrCP gene in gastric cancer.
###end article-title 86
###begin article-title 87
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.
###end article-title 87
###begin article-title 88
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
###end article-title 88
###begin article-title 89
###xml 36 40 36 40 <italic>SFRP</italic>
Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
###end article-title 89
###begin article-title 90
###xml 78 93 <span type="species:ncbi:10090">transgenic mice</span>
Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice.
###end article-title 90
###begin article-title 91
###xml 99 100 99 100 <sub>2</sub>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
###end article-title 91
###begin article-title 92
###xml 39 42 39 42 <italic>Apc</italic>
###xml 47 50 43 46 <italic>716</italic>
###xml 42 50 42 46 <sup>&#916;<italic>716</italic></sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Suppression of intestinal polyposis in ApcDelta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
###end article-title 92
###begin article-title 93
###xml 8 11 8 11 <italic>Apc</italic>
###xml 114 117 114 117 <italic>Apc</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.
###end article-title 93
###begin article-title 94
###xml 198 213 <span type="species:ncbi:10090">transgenic mice</span>
Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.
###end article-title 94
###begin article-title 95
NF-kappaB functions as a tumour promoter in inflammation-associated cancer.
###end article-title 95
###begin article-title 96
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.
###end article-title 96
###begin article-title 97
Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury.
###end article-title 97
###begin article-title 98
A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth.
###end article-title 98
###begin article-title 99
Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation.
###end article-title 99
###begin article-title 100
###xml 75 78 75 78 <italic>Apc</italic>
###xml 83 86 79 82 <italic>716</italic>
###xml 78 86 78 82 <sup>&#916;<italic>716</italic></sup>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcDelta716 knockout mice.
###end article-title 100
###begin article-title 101
###xml 14 20 11 17 <italic>CTNNB1</italic>
beta-Catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
###end article-title 101
###begin article-title 102
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Wnt signaling and gastrointestinal tumorigenesis in mouse models.
###end article-title 102
###begin article-title 103
Wnt signaling controls the phosphorylation status of beta-catenin.
###end article-title 103
###begin article-title 104
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.
###end article-title 104
###begin article-title 105
P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin.
###end article-title 105
###begin p 106
###xml 93 101 90 98 <italic>K19-Wnt1</italic>
###xml 118 119 115 116 <bold>A</bold>
###xml 176 184 173 181 <italic>K19-Wnt1</italic>
###xml 451 452 448 449 <bold>B</bold>
###xml 453 454 450 451 <bold>E</bold>
###xml 456 457 453 454 <bold>G</bold>
###xml 464 465 461 462 <bold>H</bold>
###xml 466 467 463 464 <bold>J</bold>
###xml 1066 1067 1051 1052 <bold>F</bold>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Macrophage accumulation and nuclear localization of beta-catenin in dysplastic lesion of the K19-Wnt1 mouse stomach. (A) Representative histology of a dysplastic lesion in the K19-Wnt1 glandular stomach (H&E staining). The arrowheads indicate the dysplastic mucosal area. The arrows indicate submucosal inflammatory infiltration. High-magnifications of boxed area (D, dysplastic lesion; and N, adjacent normal mucosa) in serial sections are shown in (B-E, G) and (H-J), respectively. Immunostaining results for macrophage marker F4/80 (B, H), beta-catenin (C, I), Ki-67 (D, J), and BrdU (G) are shown. The arrowheads in (B, H) indicate mucosal macrophages. The inset in (C) indicates the nuclear localization of beta-catenin in epithelial cells, whereas the inset in (I) indicates weak cytoplasmic accumulation of beta-catenin. The arrows in (D, G) indicate proliferating cells that are positive for Ki-67 and BrdU, respectively. (E) Double immunofluorescence staining for F4/80 (red) and beta-catenin (green) in dysplastic lesion. Arrowheads indicate macrophages. (F) The mean ratio of beta-catenin-accumulated epithelial cells and the mean number of infiltrated macrophages per field in the dysplastic lesion and adjacent normal mucosa. The arrows in (I, J) indicate normal progenitor cells localized in gland neck with mild accumulation of beta-catenin and positive Ki-67 staining. Bars indicate 100 mum.
###end p 106
###begin p 107
###xml 70 71 70 71 <bold>A</bold>
###xml 73 74 73 74 <bold>C</bold>
###xml 125 128 125 128 <italic>Apc</italic>
###xml 133 136 129 132 <italic>716</italic>
###xml 128 136 128 132 <sup>&#916;<italic>716</italic></sup>
###xml 150 153 146 149 <italic>Apc</italic>
###xml 158 161 150 153 <italic>716</italic>
###xml 153 161 149 153 <sup>&#916;<italic>716</italic></sup>
###xml 161 166 153 158 <italic>op/op</italic>
###xml 298 299 290 291 <bold>B</bold>
###xml 301 302 293 294 <bold>D</bold>
###xml 356 359 348 351 <italic>Apc</italic>
###xml 364 367 352 355 <italic>716</italic>
###xml 359 367 351 355 <sup>&#916;<italic>716</italic></sup>
###xml 376 379 364 367 <italic>Apc</italic>
###xml 384 387 368 371 <italic>716</italic>
###xml 379 387 367 371 <sup>&#916;<italic>716</italic></sup>
###xml 387 392 371 376 <italic>op/op</italic>
###xml 469 470 452 453 <bold>E</bold>
###xml 537 540 520 523 <italic>Apc</italic>
###xml 545 548 524 527 <italic>716</italic>
###xml 540 548 523 527 <sup>&#916;<italic>716</italic></sup>
###xml 550 554 529 533 <italic>Cont</italic>
###xml 560 563 539 542 <italic>Apc</italic>
###xml 568 571 543 546 <italic>716</italic>
###xml 563 571 542 546 <sup>&#916;<italic>716</italic></sup>
###xml 571 576 546 551 <italic>op/op</italic>
###xml 592 597 567 572 <italic>op/op</italic>
###xml 625 626 598 599 <bold>F</bold>
###xml 662 665 635 638 <italic>Apc</italic>
###xml 670 673 639 642 <italic>716</italic>
###xml 665 673 638 642 <sup>&#916;<italic>716</italic></sup>
###xml 675 679 644 648 <italic>Cont</italic>
###xml 685 688 654 657 <italic>Apc</italic>
###xml 693 696 658 661 <italic>716</italic>
###xml 688 696 657 661 <sup>&#916;<italic>716</italic></sup>
###xml 696 701 661 666 <italic>op/op</italic>
###xml 708 713 673 678 <italic>op/op</italic>
###xml 740 741 703 704 <sup>*</sup>
###xml 741 742 704 705 <italic>P</italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
Suppression of intestinal tumorigenesis by depletion of macrophages. (A, C) Representative photographs of small intestine of ApcDelta716 mice (A) and ApcDelta716op/op compound mutant mice (C) were taken using a dissecting microscope. The arrowheads indicate intestinal polyps. Bars indicate 2 mm. (B, D) F4/80 macrophage immunostaining of polyp tissues in ApcDelta716 (B) and ApcDelta716op/op compound mice (D). The arrows indicate macrophages. Bars indicate 100 mum. (E) The number of total polyps and large polyps >1 mm in diameter of ApcDelta716 (Cont) and ApcDelta716op/op compound mice (op/op) are shown as mean+/-s.d. (F) BrdU labelling index in polyps of ApcDelta716 (Cont) and ApcDelta716op/op mice (op/op) are shown as mean+/-s.d. *P<0.05 in comparison to the control.
###end p 107
###begin p 108
###xml 71 72 68 69 <bold>A</bold>
###xml 500 501 485 486 <bold>B</bold>
###xml 635 636 620 621 <bold>C</bold>
###xml 1017 1018 993 994 <bold>D</bold>
###xml 618 622 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Fluctuation of the Wnt/beta-catenin activity in gastric cancer cells. (A) Representative results of immunocytochemistry of AGS (top panels) and Kato-III (bottom panels) using anti-total beta-catenin antibody (green) and DAPI (blue) (left panels) or anti-unphosphorylated beta-catenin antibody (red) (right panels) of the same specimen. The arrows indicate cells with accumulated both total and unphosphorylated beta-catenin. The arrowheads indicate cells with weak or loss of beta-catenin staining. (B) Construction of TOPEGFP expression vector. EGFP cDNA was inserted between TCF-binding site/TK minimum promoter and SV40 pA signal. (C) Representative results of immunocytochemistry of Kato-III-GFP cells transiently transfected with pcDNA3-S33A-beta-catenin for 72 h. GFP expression (green) with DAPI staining (blue) (left panel), and unphosphorylated beta-catenin (red) of the same specimen (right panel) are shown. The arrows indicate the cell cluster with elevated GFP and unphosphorylated beta-catenin levels. (D) Representative results of flow cytometry for GFP fluorescence of AGS-GFP (top) and Kato-III-GFP (bottom) cells. Flow cytometry results of the isolated high-GFP (top 5%, red line) and low-GFP (bottom 5%, blue line) populations at 0 h (centre) and 5 days (right) after isolation by cell sorting.
###end p 108
###begin p 109
###xml 98 99 95 96 <bold>A</bold>
###xml 101 102 98 99 <bold>B</bold>
###xml 545 546 542 543 <bold>C</bold>
###xml 852 853 845 846 <bold>D</bold>
Enhancement of Wnt/beta-catenin signalling by the activated macrophages in gastric cancer cells. (A, B) Representative results of flow cytometry of AGS-GFP (A) and Kato-III-GFP cells (B). The cells were treated with CM-LPS (+) (top), CM-LPS (-) (middle) or LPS alone (bottom) at various concentrations indicated on top of each panel. The red area in each panel indicates a population with a high GFP intensity corresponding to the top 2% of the control cells (left). The percentage of high-GFP population (red area) is indicated in each panel. (C) Representative flow cytometry of AGS-GFP (top) and Kato-III-GFP (bottom) treated with CM-LPS (+) alone (centre) or CM-LPS (+) with anti-TNF-alpha-neutralizing antibody (right). The percentage of a high-GFP population (red area corresponding to top 2% in control cells, left) is indicated in each panel. (D) Representative flow cytometry results of AGS-GFP (top) and Kato-III-GFP (bottom) treated with TNF-alpha (red lines) and untreated control (black lines). The percentage of high GFP in TNF-alpha-treated cells (corresponding to top 2% in control cells, grey area) is indicated in each panel.
###end p 109
###begin p 110
###xml 97 98 90 91 <bold>A</bold>
###xml 494 495 477 478 <bold>B</bold>
###xml 735 736 705 706 <bold>C</bold>
###xml 1082 1083 1042 1043 <bold>D</bold>
Suppression of beta-catenin phosphorylation by CM-LPS (+) or TNF-alpha in gastric cancer cells. (A) Representative flow cytometry results of Kato-III cells using an antibody against unphosphorylated beta-catenin on Ser37 and Thr41 are shown. The cells were treated with CM-LPS (+) (centre) or TNF-alpha (right) for 24 h. The red area indicates population with high level of unphosphorylated beta-catenin: top 10% in control cells (left). The percentage of red area is indicated in each panel. (B) Western blotting of Kato-III cells for total beta-catenin (top) and unphosphorylated beta-catenin (middle). The cells were treated with CM-LPS (+) (CM) or TNF-alpha at 10 ng/ml (TNF). beta-Actin was used as an internal control (bottom). (C) Western blotting of AGS cells (left) and Kato-III cells (right) for total and phosphorylated GSK3beta on Ser9, and phosphorylated Akt on Ser473. beta-Actin was used as an internal control. The cells were treated with TNF-alpha at 100 ng/ml (TNF) in serum-free conditions. The results of three independent samples are shown for each cell line. (D) Representative immunocytochemistry for phosphorylated GSK3 (p-GSK, green) and DAPI (blue) (left) and unphosphorylated beta-catenin (red) (right) of the same specimen. The arrows indicate cells with strong staining for both p-GSK and beta-catenin, whereas the arrowheads indicate cells with weak staining for both.
###end p 110
###begin p 111
###xml 78 79 71 72 <bold>A</bold>
###xml 324 325 295 296 <bold>B</bold>
###xml 650 651 609 610 <bold>C</bold>
NF-kappaB-independent promotion of the Wnt/beta-catenin signalling activity. (A) The level of NF-kappaB activity in the TNF-alpha-treated (TNF) or untreated control (Con.) cells (mean+/-s.d.). IkappaBSR nos. 1 and 2 are AGS-GFP-derived stable transfectants with IkappaBSR, whereas IkappaBSR (-) indicates parental AGS-GFP. (B) Representative flow cytometry results of IkappaBSR(-), IkappaBSR nos. 1 and 2 cells (left to right) treated with TNF-alpha (top) or CM-LPS (+) (bottom) at the indicated concentrations (red lines). The percentage of high-GFP populations (corresponding to top 2% in untreated cells, black lines) is indicated in each panel. (C) Flow cytometry results of Kato-III cells using antibody against unphosphorylated beta-catenin. The cells were treated with cycloheximide alone (black line) or cycloheximide and CM-LPS (+) (red line) for 2, 4, 8 and 12 h. The percentages of the population with high level of unphosphorylated beta-catenin are indicated in each panel (red, cycloheximide and CM-LPS (+); black, cycloheximide alone).
###end p 111
###begin p 112
###xml 49 57 46 54 <italic>H. felis</italic>
###xml 85 93 82 90 <italic>K19-Wnt1</italic>
###xml 101 102 98 99 <bold>A</bold>
###xml 103 104 100 101 <bold>F</bold>
###xml 166 174 163 171 <italic>K19-Wnt1</italic>
###xml 194 202 191 199 <italic>H. felis</italic>
###xml 217 218 214 215 <bold>G</bold>
###xml 219 220 216 217 <bold>L</bold>
###xml 269 277 266 274 <italic>K19-Wnt1</italic>
###xml 430 431 424 425 <sup>+</sup>
###xml 433 434 427 428 <sup>+</sup>
###xml 650 662 643 655 <italic>Helicobacter</italic>
###xml 856 857 846 847 <sup>+</sup>
###xml 859 860 849 850 <sup>+</sup>
###xml 1171 1172 1155 1156 <bold>M</bold>
###xml 1182 1183 1166 1167 <bold>N</bold>
###xml 1191 1192 1175 1176 <sup>+</sup>
###xml 1194 1195 1178 1179 <sup>+</sup>
###xml 1204 1205 1188 1189 <bold>O</bold>
###xml 1306 1307 1288 1289 <italic>P</italic>
###xml 49 57 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 194 202 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
The activation of Wnt/beta-catenin signalling in H. felis-infected gastric mucosa of K19-Wnt1 mice. (A-F) Representative histology of inflamed gastric mucosa (IM) of K19-Wnt1 mice infected with H. felis for 8 weeks. (G-L) Non-inflamed gastric mucosal (NIM) area of the K19-Wnt1 mice. H&E staining (A, G), high magnified H&E staining (B, H), immunostaining for F4/80 (C, I), unphosphorylated beta-catenin (D, J), Ki-67 (E, K) and H+/K+-ATPase (F, L). Bars in (B, H) and other panels indicate 50 and 100 mum, respectively. The arrows in (A, C) indicate infiltrated mononuclear cells and macrophages, respectively. The yellow arrowheads in (B) indicate Helicobacter bacteria in the gland lumen, which is not found in NIM (H). The arrows in (D, E) indicate beta-catenin-accumulated and proliferating epithelial cells, respectively. The arrows in (F) indicate H+/K+-ATPase-positive parietal cells that are dramatically decreased in IM compared with NIM (L). The arrows in (J, K) indicate progenitor cells with cytoplasmic beta-catenin accumulation and Ki-67-positive proliferation, respectively. The mean numbers of positive cells per gland for unphosphorylated beta-catenin (M), Ki-67 (N), and H+/K+-ATPase (O) in IM (red bars) and NIM (blue bars) are shown as histograms (mean+/-s.d.). The asterisks indicate P<0.05.
###end p 112
###begin p 113
###xml 22 30 22 30 <italic>H. felis</italic>
###xml 40 48 40 48 <italic>K19-Wnt1</italic>
###xml 64 72 64 72 <italic>K19-Wnt1</italic>
###xml 74 75 74 75 <bold>A</bold>
###xml 76 77 76 77 <bold>D</bold>
###xml 94 95 94 95 <bold>E</bold>
###xml 96 97 96 97 <bold>H</bold>
###xml 127 135 127 135 <italic>H. felis</italic>
###xml 256 264 256 264 <italic>K19-Wnt1</italic>
###xml 22 30 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 127 135 <span type="species:ncbi:294745|species:ncbi:214|species:ncbi:123822|species:ncbi:75286|species:ncbi:29501">H. felis</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
Tumour development in H. felis-infected K19-Wnt1 mouse stomach. K19-Wnt1 (A-D) and wild-type (E-H) mouse stomach infected with H. felis for 20 weeks. (A, E) Macroscopic photographs. The arrows in (A) indicate gastric tumours that developed in the infected K19-Wnt1 mice. H&E staining at low magnification (B, F) and high magnification (D, H). Immunostaining results for macrophage marker F4/80 (C, G). The arrows in (B, F) indicate submucosal infiltration. The arrowheads in (D) indicate dysplastic epithelial cells. Bars in (B, F) and (C, D, G, H) indicate 200 and 40 mum, respectively.
###end p 113

